FATE THERAPEUTICS (FATE) stock: insider trades, news & valuation
Net sellingShare price and insider trades
FATE THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $323K of FATE stock on the open market.
Get emailed when insiders cluster-buy stocks like FATE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
FATE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $204K | 2 |
| Q2 2026 | — | 0 | $103K | 2 |
| Q1 2026 | — | 0 | $17K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 FATE THERAPEUTICS INC insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $323K. 0 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 5SEC | Bahram ValamehrCEO, President | Sell | 43,947591,815 held (−7%) | $2.46 | $108K | -11.4% | — |
| Aug 5SEC | Cindy TahlSee Remarks | Sell | 38,800589,355 held (−6%) | $2.46 | $95K | -11.4% | — |
| May 21SEC | Bahram ValamehrCEO, President | Sell | 28,946635,762 held (−4%) | $1.88 | $54K | +16.0% | — |
| May 21SEC | Cindy TahlSee Remarks | Sell | 25,590628,155 held (−4%) | $1.88 | $48K | +16.0% | — |
| Jan 12SEC | Cindy TahlSee Remarks | Sell | 10,589387,081 held (−3%) | $1.06 | $11K | +105.7% | — |
| Jan 12SEC | Bahram ValamehrCEO, President | Sell | 5,190329,708 held (−2%) | $1.07 | $6K | +103.7% | — |
Insiders at FATE THERAPEUTICS INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Bahram ValamehrCEO, President | — | $168K | Aug 5, 2026 | — |
| Cindy TahlSee Remarks | — | $155K | Aug 5, 2026 | — |
FATE stock: common questions
Are FATE THERAPEUTICS INC insiders buying FATE stock?
In the past 12 months, 0 insiders reported open-market purchases of FATE worth $0.
Are FATE THERAPEUTICS INC insiders selling FATE stock?
2 insiders reported sales worth $323K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is FATE's 52-week range?
Over the past year FATE has traded between $0.96 and $3.11. It last closed at $2.18 on Oct 9, 2026.